25 XP   0   0   10

LBT Innovations Ltd
Buy, Hold or Sell?

Let's analyse LBT Innovations Ltd together

PenkeI guess you are interested in LBT Innovations Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of LBT Innovations Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about LBT Innovations Ltd

I send you an email if I find something interesting about LBT Innovations Ltd.

Quick analysis of LBT Innovations Ltd (30 sec.)










What can you expect buying and holding a share of LBT Innovations Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.06
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
A$-0.06
Return On Investment
-307.0%

For what price can you sell your share?

Current Price per Share
A$0.02
Expected price per share
A$0.019 - A$0.026
How sure are you?
50%

1. Valuation of LBT Innovations Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.02

Intrinsic Value Per Share

A$-0.03 - A$-0.01

Total Value Per Share

A$-0.03 - A$-0.01

2. Growth of LBT Innovations Ltd (5 min.)




Is LBT Innovations Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?-$67.2k$13.6m-$13.7m-20,419.0%

How much money is LBT Innovations Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$14.4m-$4.2m-$10.1m-70.5%
Net Profit Margin-1,056.5%-312.1%--

How much money comes from the company's main activities?

3. Financial Health of LBT Innovations Ltd (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#311 / 340

Most Revenue
#264 / 340

Most Profit
#282 / 340

Most Efficient
#303 / 340

What can you expect buying and holding a share of LBT Innovations Ltd? (5 min.)

Welcome investor! LBT Innovations Ltd's management wants to use your money to grow the business. In return you get a share of LBT Innovations Ltd.

What can you expect buying and holding a share of LBT Innovations Ltd?

First you should know what it really means to hold a share of LBT Innovations Ltd. And how you can make/lose money.

Speculation

The Price per Share of LBT Innovations Ltd is A$0.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of LBT Innovations Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in LBT Innovations Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of LBT Innovations Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-54.0%-0.01-54.0%0.00-15.9%0.00-22.3%0.00-12.0%
Usd Book Value Change Per Share-0.01-51.4%-0.01-51.4%0.00-8.5%0.00-14.0%0.00-3.1%
Usd Dividend Per Share0.002.3%0.002.3%0.000.0%0.003.6%0.001.8%
Usd Total Gains Per Share-0.01-49.2%-0.01-49.2%0.00-8.5%0.00-10.4%0.00-1.3%
Usd Price Per Share0.03-0.03-0.07-0.10-0.12-
Price to Earnings Ratio-2.54--2.54--22.39--34.63-114.68-
Price-to-Total Gains Ratio-2.79--2.79--41.95-85.67-120.67-
Price to Book Ratio-545.39--545.39-6.97--101.39--43.23-
Price-to-Total Gains Ratio-2.79--2.79--41.95-85.67-120.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.012808
Number of shares78076
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (78076 shares)-767.61-162.53
Gains per Year (78076 shares)-3,070.43-650.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1142-3212-3080225-875-660
2284-6425-6150451-1751-1310
3426-9637-9220676-2626-1960
4568-12849-12290901-3502-2610
5709-16062-153601127-4377-3260
6851-19274-184301352-5252-3910
7993-22486-215001577-6128-4560
81135-25699-245701802-7003-5210
91277-28911-276402028-7879-5860
101419-32123-307102253-8754-6510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%3.07.00.030.0%8.09.02.042.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%13.06.00.068.4%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%3.00.02.060.0%3.00.07.030.0%3.00.016.015.8%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%13.06.00.068.4%

Fundamentals of LBT Innovations Ltd

About LBT Innovations Ltd

LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring. The company's products pipeline also includes Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; Biofilm, a device for detecting the biofilms in the presence of mammalian tissues; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.

Fundamental data was last updated by Penke on 2024-04-01 07:23:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of LBT Innovations Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit LBT Innovations Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare LBT Innovations Ltd to the Medical Devices industry mean.
  • A Net Profit Margin of -1,056.5% means that $-10.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of LBT Innovations Ltd:

  • The MRQ is -1,056.5%. The company is making a huge loss. -2
  • The TTM is -1,056.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,056.5%TTM-1,056.5%0.0%
TTM-1,056.5%YOY-312.1%-744.4%
TTM-1,056.5%5Y-534.1%-522.4%
5Y-534.1%10Y-273.1%-261.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,056.5%-11.2%-1,045.3%
TTM-1,056.5%-19.6%-1,036.9%
YOY-312.1%-14.4%-297.7%
5Y-534.1%-21.3%-512.8%
10Y-273.1%-24.8%-248.3%
1.1.2. Return on Assets

Shows how efficient LBT Innovations Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare LBT Innovations Ltd to the Medical Devices industry mean.
  • -305.6% Return on Assets means that LBT Innovations Ltd generated $-3.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of LBT Innovations Ltd:

  • The MRQ is -305.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -305.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-305.6%TTM-305.6%0.0%
TTM-305.6%YOY-21.1%-284.6%
TTM-305.6%5Y-75.0%-230.6%
5Y-75.0%10Y-38.5%-36.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-305.6%-4.0%-301.6%
TTM-305.6%-4.5%-301.1%
YOY-21.1%-4.8%-16.3%
5Y-75.0%-4.0%-71.0%
10Y-38.5%-5.2%-33.3%
1.1.3. Return on Equity

Shows how efficient LBT Innovations Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare LBT Innovations Ltd to the Medical Devices industry mean.
  • 0.0% Return on Equity means LBT Innovations Ltd generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of LBT Innovations Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-31.1%+31.1%
TTM-5Y-19.7%+19.7%
5Y-19.7%10Y-10.9%-8.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.9%+3.9%
TTM--5.6%+5.6%
YOY-31.1%-5.9%-25.2%
5Y-19.7%-6.1%-13.6%
10Y-10.9%-7.1%-3.8%

1.2. Operating Efficiency of LBT Innovations Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient LBT Innovations Ltd is operating .

  • Measures how much profit LBT Innovations Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare LBT Innovations Ltd to the Medical Devices industry mean.
  • An Operating Margin of -334.9% means the company generated $-3.35  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of LBT Innovations Ltd:

  • The MRQ is -334.9%. The company is operating very inefficient. -2
  • The TTM is -334.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-334.9%TTM-334.9%0.0%
TTM-334.9%YOY-371.2%+36.3%
TTM-334.9%5Y-397.8%+62.9%
5Y-397.8%10Y-218.2%-179.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-334.9%-22.8%-312.1%
TTM-334.9%-17.1%-317.8%
YOY-371.2%-13.4%-357.8%
5Y-397.8%-19.2%-378.6%
10Y-218.2%-24.0%-194.2%
1.2.2. Operating Ratio

Measures how efficient LBT Innovations Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 4.35 means that the operating costs are $4.35 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of LBT Innovations Ltd:

  • The MRQ is 4.349. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.349. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.349TTM4.3490.000
TTM4.349YOY4.712-0.363
TTM4.3495Y4.816-0.467
5Y4.81610Y3.154+1.662
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3491.428+2.921
TTM4.3491.426+2.923
YOY4.7121.503+3.209
5Y4.8161.440+3.376
10Y3.1541.371+1.783

1.3. Liquidity of LBT Innovations Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if LBT Innovations Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.16 means the company has $1.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of LBT Innovations Ltd:

  • The MRQ is 1.156. The company is just able to pay all its short-term debts.
  • The TTM is 1.156. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.156TTM1.1560.000
TTM1.156YOY2.444-1.288
TTM1.1565Y4.955-3.799
5Y4.95510Y3.900+1.055
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1562.787-1.631
TTM1.1562.763-1.607
YOY2.4443.488-1.044
5Y4.9553.617+1.338
10Y3.9003.514+0.386
1.3.2. Quick Ratio

Measures if LBT Innovations Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare LBT Innovations Ltd to the Medical Devices industry mean.
  • A Quick Ratio of 0.80 means the company can pay off $0.80 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of LBT Innovations Ltd:

  • The MRQ is 0.800. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.800. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.800TTM0.8000.000
TTM0.800YOY2.100-1.300
TTM0.8005Y4.606-3.806
5Y4.60610Y3.283+1.323
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8001.539-0.739
TTM0.8001.660-0.860
YOY2.1002.139-0.039
5Y4.6062.300+2.306
10Y3.2832.255+1.028

1.4. Solvency of LBT Innovations Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of LBT Innovations Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare LBT Innovations Ltd to Medical Devices industry mean.
  • A Debt to Asset Ratio of 1.01 means that LBT Innovations Ltd assets are financed with 101.4% credit (debt) and the remaining percentage (100% - 101.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of LBT Innovations Ltd:

  • The MRQ is 1.014. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.014. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.014TTM1.0140.000
TTM1.014YOY0.323+0.691
TTM1.0145Y0.430+0.584
5Y0.43010Y0.377+0.054
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0140.389+0.625
TTM1.0140.386+0.628
YOY0.3230.338-0.015
5Y0.4300.442-0.012
10Y0.3770.460-0.083
1.4.2. Debt to Equity Ratio

Measures if LBT Innovations Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare LBT Innovations Ltd to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of LBT Innovations Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.478-0.478
TTM-5Y0.321-0.321
5Y0.32110Y0.407-0.086
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.559-0.559
TTM-0.560-0.560
YOY0.4780.4780.000
5Y0.3210.624-0.303
10Y0.4070.674-0.267

2. Market Valuation of LBT Innovations Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings LBT Innovations Ltd generates.

  • Above 15 is considered overpriced but always compare LBT Innovations Ltd to the Medical Devices industry mean.
  • A PE ratio of -2.54 means the investor is paying $-2.54 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of LBT Innovations Ltd:

  • The EOD is -1.185. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.542. Based on the earnings, the company is expensive. -2
  • The TTM is -2.542. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.185MRQ-2.542+1.357
MRQ-2.542TTM-2.5420.000
TTM-2.542YOY-22.392+19.849
TTM-2.5425Y-34.629+32.087
5Y-34.62910Y114.684-149.313
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.185-1.037-0.148
MRQ-2.542-1.578-0.964
TTM-2.542-2.041-0.501
YOY-22.392-2.971-19.421
5Y-34.629-2.058-32.571
10Y114.684-1.463+116.147
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of LBT Innovations Ltd:

  • The EOD is -15.677. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -33.626. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -33.626. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.677MRQ-33.626+17.950
MRQ-33.626TTM-33.6260.000
TTM-33.626YOY-26.535-7.091
TTM-33.6265Y-153.781+120.155
5Y-153.78110Y-50.233-103.548
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-15.677-1.007-14.670
MRQ-33.626-1.544-32.082
TTM-33.626-3.018-30.608
YOY-26.535-6.339-20.196
5Y-153.781-4.928-148.853
10Y-50.233-4.950-45.283
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of LBT Innovations Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -545.39 means the investor is paying $-545.39 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of LBT Innovations Ltd:

  • The EOD is -254.259. Based on the equity, the company is expensive. -2
  • The MRQ is -545.386. Based on the equity, the company is expensive. -2
  • The TTM is -545.386. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-254.259MRQ-545.386+291.127
MRQ-545.386TTM-545.3860.000
TTM-545.386YOY6.970-552.356
TTM-545.3865Y-101.394-443.992
5Y-101.39410Y-43.228-58.165
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-254.2591.987-256.246
MRQ-545.3862.379-547.765
TTM-545.3862.444-547.830
YOY6.9703.215+3.755
5Y-101.3943.833-105.227
10Y-43.2284.163-47.391
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of LBT Innovations Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of LBT Innovations Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.016-0.0160%-0.003-83%-0.004-73%-0.001-94%
Book Value Per Share--0.0000.0000%0.016-100%0.015-101%0.015-101%
Current Ratio--1.1561.1560%2.444-53%4.955-77%3.900-70%
Debt To Asset Ratio--1.0141.0140%0.323+214%0.430+136%0.377+169%
Debt To Equity Ratio----0%0.478-100%0.321-100%0.407-100%
Dividend Per Share--0.0010.0010%-+100%0.001-37%0.001+26%
Eps---0.017-0.0170%-0.005-71%-0.007-59%-0.004-78%
Free Cash Flow Per Share---0.001-0.0010%-0.004+229%-0.002+61%-0.001+6%
Free Cash Flow To Equity Per Share---0.001-0.0010%-0.005+713%0.000-299%0.001-148%
Gross Profit Margin--1.0041.0040%1.020-2%1.012-1%0.971+3%
Intrinsic Value_10Y_max---0.010--------
Intrinsic Value_10Y_min---0.028--------
Intrinsic Value_1Y_max---0.001--------
Intrinsic Value_1Y_min---0.003--------
Intrinsic Value_3Y_max---0.004--------
Intrinsic Value_3Y_min---0.008--------
Intrinsic Value_5Y_max---0.006--------
Intrinsic Value_5Y_min---0.014--------
Market Cap26697200.640-115%57265495.37357265495.3730%148703407.565-61%201777442.437-72%241996775.201-76%
Net Profit Margin---10.565-10.5650%-3.121-70%-5.341-49%-2.731-74%
Operating Margin---3.349-3.3490%-3.712+11%-3.978+19%-2.182-35%
Operating Ratio--4.3494.3490%4.712-8%4.816-10%3.154+38%
Pb Ratio-254.259+53%-545.386-545.3860%6.970-7925%-101.394-81%-43.228-92%
Pe Ratio-1.185+53%-2.542-2.5420%-22.392+781%-34.629+1262%114.684-102%
Price Per Share0.020-115%0.0430.0430%0.111-61%0.151-72%0.181-76%
Price To Free Cash Flow Ratio-15.677+53%-33.626-33.6260%-26.535-21%-153.781+357%-50.233+49%
Price To Total Gains Ratio-1.303+53%-2.794-2.7940%-41.947+1401%85.668-103%120.670-102%
Quick Ratio--0.8000.8000%2.100-62%4.606-83%3.283-76%
Return On Assets---3.056-3.0560%-0.211-93%-0.750-75%-0.385-87%
Return On Equity----0%-0.3110%-0.1970%-0.1090%
Total Gains Per Share---0.015-0.0150%-0.003-83%-0.003-79%0.000-97%
Usd Book Value---67242.000-67242.0000%13662934.000-100%12774699.200-101%12723467.200-101%
Usd Book Value Change Per Share---0.010-0.0100%-0.002-83%-0.003-73%-0.001-94%
Usd Book Value Per Share--0.0000.0000%0.010-100%0.010-101%0.010-101%
Usd Dividend Per Share--0.0000.0000%-+100%0.001-37%0.000+26%
Usd Eps---0.011-0.0110%-0.003-71%-0.004-59%-0.002-78%
Usd Free Cash Flow---1090601.200-1090601.2000%-3588801.600+229%-1754183.680+61%-1160020.560+6%
Usd Free Cash Flow Per Share---0.001-0.0010%-0.003+229%-0.001+61%-0.001+6%
Usd Free Cash Flow To Equity Per Share--0.0000.0000%-0.003+713%0.000-299%0.001-148%
Usd Market Cap17096887.290-115%36672823.23736672823.2370%95229662.204-61%129218274.137-72%154974734.839-76%
Usd Price Per Share0.013-115%0.0270.0270%0.071-61%0.097-72%0.116-76%
Usd Profit---14424369.600-14424369.6000%-4252896.400-71%-5944320.880-59%-3204497.560-78%
Usd Revenue--1365332.8001365332.8000%1362771.200+0%1165271.840+17%2202271.560-38%
Usd Total Gains Per Share---0.010-0.0100%-0.002-83%-0.002-79%0.000-97%
 EOD+2 -6MRQTTM+0 -0YOY+15 -205Y+9 -2610Y+10 -25

4.2. Fundamental Score

Let's check the fundamental score of LBT Innovations Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.185
Price to Book Ratio (EOD)Between0-1-254.259
Net Profit Margin (MRQ)Greater than0-10.565
Operating Margin (MRQ)Greater than0-3.349
Quick Ratio (MRQ)Greater than10.800
Current Ratio (MRQ)Greater than11.156
Debt to Asset Ratio (MRQ)Less than11.014
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.056
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of LBT Innovations Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.158
Ma 20Greater thanMa 500.024
Ma 50Greater thanMa 1000.019
Ma 100Greater thanMa 2000.016
OpenGreater thanClose0.020
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-06-302020-06-302021-06-302022-06-302023-06-30
Total Stockholder Equity 29,518-5,40624,11276824,880-3,54521,335-21,440-105
Net Tangible Assets  29,518-5,40624,11276824,880-3,54521,335-21,440-105
Tax Provision  -1,644-135-1,779-465-2,244126-2,1183,7591,641
Income Tax Expense  -1,644-135-1,779-465-2,244126-2,1183,7591,641



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets7,370
Total Liabilities7,475
Total Stockholder Equity-105
 As reported
Total Liabilities 7,475
Total Stockholder Equity+ -105
Total Assets = 7,370

Assets

Total Assets7,370
Total Current Assets4,841
Long-term Assets2,529
Total Current Assets
Cash And Cash Equivalents 2,020
Net Receivables 1,331
Inventory 1,490
Total Current Assets  (as reported)4,841
Total Current Assets  (calculated)4,841
+/-0
Long-term Assets
Property Plant Equipment 1,673
Other Assets 856
Long-term Assets  (as reported)2,529
Long-term Assets  (calculated)2,529
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,189
Long-term Liabilities3,286
Total Stockholder Equity-105
Total Current Liabilities
Short-term Debt 1,194
Short Long Term Debt 986
Accounts payable 680
Other Current Liabilities 2,024
Total Current Liabilities  (as reported)4,189
Total Current Liabilities  (calculated)4,884
+/- 695
Long-term Liabilities
Long term Debt Total 2,193
Other Liabilities 1,093
Long-term Liabilities  (as reported)3,286
Long-term Liabilities  (calculated)3,286
+/- 0
Total Stockholder Equity
Common Stock47,017
Retained Earnings -49,069
Accumulated Other Comprehensive Income 1,947
Total Stockholder Equity (as reported)-105
Total Stockholder Equity (calculated)-105
+/-0
Other
Capital Stock47,017
Cash And Equivalents160
Cash and Short Term Investments 2,020
Common Stock Shares Outstanding 471,249
Current Deferred Revenue291
Liabilities and Stockholders Equity 7,370
Net Debt 1,367
Net Invested Capital 1,638
Net Tangible Assets -105
Net Working Capital 652
Property Plant and Equipment Gross 2,368
Short Long Term Debt Total 3,387



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-30
> Total Assets 
4,894
2,468
16,657
19,585
19,837
21,152
19,822
18,381
18,757
22,448
24,574
30,272
30,470
36,109
38,125
33,765
35,689
31,524
7,370
7,37031,52435,68933,76538,12536,10930,47030,27224,57422,44818,75718,38119,82221,15219,83719,58516,6572,4684,894
   > Total Current Assets 
4,290
0
9,211
4,423
3,423
5,364
3,674
3,550
3,984
5,296
4,481
6,538
10,220
9,484
11,487
7,933
11,567
6,979
4,841
4,8416,97911,5677,93311,4879,48410,2206,5384,4815,2963,9843,5503,6745,3643,4234,4239,21104,290
       Cash And Cash Equivalents 
4,177
858
8,976
3,942
3,214
5,060
3,320
2,932
876
1,791
1,818
4,682
3,498
7,572
10,175
7,096
9,615
2,788
2,020
2,0202,7889,6157,09610,1757,5723,4984,6821,8181,7918762,9323,3205,0603,2143,9428,9768584,177
       Net Receivables 
112
62
235
481
209
304
354
362
2,281
491
838
525
2,365
251
302
837
1,952
3,210
1,331
1,3313,2101,9528373022512,3655258384912,28136235430420948123562112
       Other Current Assets 
0
532
0
0
0
0
0
256
827
3,014
1,825
1,331
4,357
1,661
1,010
785
1,286
1,471
1,011
1,0111,4711,2867851,0101,6614,3571,3311,8253,014827256000005320
   > Long-term Assets 
604
0
7,446
15,162
16,414
15,788
16,148
14,831
14,773
17,152
20,093
23,734
20,250
26,625
26,638
25,832
24,122
24,545
2,529
2,52924,54524,12225,83226,63826,62520,25023,73420,09317,15214,77314,83116,14815,78816,41415,1627,4460604
       Property Plant Equipment 
0
701
8
11,121
12,037
11,977
11,758
11,087
10,411
13,694
62
44
65
90
89
72
2,079
1,919
1,673
1,6731,9192,07972899065446213,69410,41111,08711,75811,97712,03711,12187010
       Long Term Investments 
0
0
0
0
0
0
0
0
0
1,507
1,675
1,479
4,096
7,896
7,115
7,293
4,687
0
0
004,6877,2937,1157,8964,0961,4791,6751,507000000000
       Intangible Assets 
604
152
5,812
359
335
311
287
264
241
216
16,868
20,583
15,864
18,122
18,119
16,558
14,822
16,154
0
016,15414,82216,55818,11918,12215,86420,58316,8682162412642873113353595,812152604
       Long-term Assets Other 
1
0
0
0
0
0
0
0
0
0
0
0
0
26,625
350
370
0
-1,919
0
0-1,919037035026,6250000000000001
> Total Liabilities 
216
884
4,520
6,699
6,600
6,474
6,354
6,069
5,907
8,884
8,890
11,082
9,077
7,000
8,607
9,653
10,809
10,189
7,475
7,47510,18910,8099,6538,6077,0009,07711,0828,8908,8845,9076,0696,3546,4746,6006,6994,520884216
   > Total Current Liabilities 
216
884
2,849
884
430
344
300
430
609
2,813
2,061
2,476
4,194
1,864
969
1,638
2,584
2,856
4,189
4,1892,8562,5841,6389691,8644,1942,4762,0612,8136094303003444308842,849884216
       Short-term Debt 
0
0
10
0
0
0
0
0
0
0
1,054
0
0
0
271
934
1,130
1,157
1,194
1,1941,1571,1309342710001,05400000001000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
1,000
0
0
0
271
949
951
965
986
9869659519492710001,0000000000000
       Accounts payable 
11
376
1,424
875
417
307
263
289
468
2,672
866
1,965
4,194
1,864
698
678
1,408
823
680
6808231,4086786981,8644,1941,9658662,6724682892633074178751,42437611
       Other Current Liabilities 
161
66
1,414
9
13
37
37
141
141
141
195
0
-141
0
0
26
6
847
2,024
2,02484762600-141019514114114137371391,41466161
   > Long-term Liabilities 
0
0
1,671
5,815
6,170
6,130
6,054
5,639
5,298
6,071
6,829
8,606
4,883
5,136
7,638
8,015
8,225
7,333
3,286
3,2867,3338,2258,0157,6385,1364,8838,6066,8296,0715,2985,6396,0546,1306,1705,8151,67100
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,263
2,973
3,728
3,130
2,193
2,1933,1303,7282,9732,26300000000000000
       Other Liabilities 
0
0
0
2,503
2,496
2,459
2,429
2,213
2,103
1,986
6,829
7,779
4,883
5,136
5,409
5,076
4,497
4,203
1,093
1,0934,2034,4975,0765,4095,1364,8837,7796,8291,9862,1032,2132,4292,4592,4962,503000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
13,629
16,675
20,415
15,864
18,122
18,119
16,558
14,822
16,154
0
016,15414,82216,55818,11918,12215,86420,41516,67513,629000000000
> Total Stockholder Equity
4,678
1,584
12,138
12,886
13,237
14,678
13,468
12,312
12,850
13,564
15,684
19,190
21,393
29,109
29,518
24,112
24,880
21,335
-105
-10521,33524,88024,11229,51829,10921,39319,19015,68413,56412,85012,31213,46814,67813,23712,88612,1381,5844,678
   Common Stock
4,998
852
11,797
11,504
11,412
11,347
11,299
11,299
11,297
11,665
13,187
13,152
20,881
30,855
35,565
35,549
43,544
46,271
47,017
47,01746,27143,54435,54935,56530,85520,88113,15213,18711,66511,29711,29911,29911,34711,41211,50411,7978524,998
   Retained Earnings 
-319
0
2
724
1,061
2,549
1,387
231
762
1,054
1,457
5,034
-99
-2,784
-7,134
-12,713
-19,961
-26,587
-49,069
-49,069-26,587-19,961-12,713-7,134-2,784-995,0341,4571,0547622311,3872,5491,06172420-319
   Capital Surplus 0000000000000000000
   Treasury Stock0000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
-859
-761
-877
-1,608
-1,644
-1,875
0
-2,211
-1,932
-1,826
-1,826-1,932-2,2110-1,875-1,644-1,608-877-761-859000000000



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.